ZEB2 and cancer: This study provided enough data to support that the miR-6734-3p/ZEB2 axis was crucial for regulating cancer progression and cisplatin-resistance; however, all our current data were based on the preliminary cellular and animal experiments, future clinical analysis was still needed to verify those results and conclusions in clinic.